Where GLP-1 Patches Fit Into the Future of Treatment
Discover how GLP-1 patches may reshape metabolic health care. Learn how they work and what the future may hold.
Wondering if Ozempic is semaglutide? Learn what’s in it, how it’s used, and how it compares to other semaglutide treatments.
This content is for informational purposes only and does not constitute medical advice. Medications like semaglutide are only prescribed when clinically appropriate and are dispensed through state-licensed pharmacies. Eden is not a pharmacy or healthcare provider.
If you’ve been researching GLP-1 medications, you’ve likely come across both the term “semaglutide” and the brand name “Ozempic®.” Many people wonder whether Ozempic® is simply another name for semaglutide or if it’s something entirely different. The short answer: Ozempic® contains semaglutide as its active ingredient, but it’s a specific FDA-approved medication with its own dosing, indications, and brand-specific formulation.
Unlike articles that explore why the terms get confused or what to consider before starting, this guide focuses solely on clarifying the ingredient, brand, and approval differences so you have a clear, fact-based understanding.
Understanding the difference between a drug’s generic name and its brand name can help you make sense of your options when discussing treatment with a licensed healthcare provider. In this article, we’ll break down what semaglutide is, how Ozempic® fits into that category, and how it compares to other semaglutide-based treatments.
Semaglutide is the generic name for a type of medication called a GLP-1 receptor agonist. These medications mimic a naturally occurring hormone in the body that helps regulate blood sugar, digestion, and appetite. Because of its ability to affect both insulin release and feelings of fullness, semaglutide is used in different prescription products for different health purposes.
Ozempic® is a brand-name prescription medication that contains semaglutide as its active ingredient. However, it is specifically FDA-approved to help improve blood sugar control in adults with type 2 diabetes, and to reduce the risk of certain cardiovascular events in that population.
While some people taking Ozempic® may experience weight loss, it is not FDA-approved as a weight loss medication. Licensed providers may evaluate its use for other purposes based on clinical judgment, but brand labeling and FDA indications are clear: Ozempic® has a primary use in diabetes management.
{{primary-cta}}
Wegovy® is another brand name for a semaglutide-based medication. Unlike Ozempic®, Wegovy® is FDA-approved for chronic weight management in adults with specific health criteria, including BMI thresholds and certain weight-related conditions.
Both medications contain semaglutide but differ in:
Some patients may receive semaglutide from licensed U.S. pharmacies when prescribed by a licensed healthcare provider. All prescriptions must be filled by pharmacies that follow applicable state and federal safety and quality regulations.
Knowing whether you’re discussing Ozempic®, Wegovy®, or another semaglutide formulation is important for several reasons:
A licensed provider can clarify which option, if any, fits your health needs and goals.
{{primary-cta}}
Whether it’s Ozempic®, Wegovy®, or another semaglutide treatment prescribed by a licensed healthcare provider, safety starts with proper medical evaluation. On Eden’s platform, this includes:
Eden does not sell or produce medications. Our role is to connect you with independent licensed medical providers who make evidence-based prescribing decisions and ensure your treatment is sourced safely.
Ozempic® is semaglutide, but it’s a specific brand with its own approved uses, primarily for type 2 diabetes. If your goal is weight management, other semaglutide formulations like Wegovy® or provider-prescribed alternatives may be considered. The safest way to determine the right option is to work with a licensed healthcare provider who can evaluate your full health picture.
If you’re ready to explore whether a semaglutide-based treatment may be right for you, Eden can connect you with independent licensed medical providers for a personalized assessment.
Start your online evaluation today.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
Eden is not a medical provider or a pharmacy. Eden connects individuals with independent licensed healthcare providers who independently evaluate each patient to determine whether a prescription treatment program is appropriate. All prescriptions are written at the sole discretion of the licensed provider. Medications are filled by independent, state-licensed pharmacies. Eden does not manufacture, own, or dispense any medications. Please consult a licensed healthcare provider before making any medical decisions.
FDA. (2025, July 29). FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
Novo Nordisk Inc. (2017). OZEMPIC. https://www.novo-pi.com/ozempic.pdf
Novo Nordisk Inc. (2023). Highlights of prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256s007lbl.pdf
Wilding, J. P., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/nejmoa2032183